World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
131
Citations
79138
World Ranking
333
National Ranking
204

Medicine

D-Index
134
Citations
81961
World Ranking
2121
National Ranking
1198

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Julie M. Vose is affiliated with the University of Nebraska Medical Center in the United States. Their research primarily spans the field of Medicine, with specific focus areas including Pathology and Forensic Medicine, Oncology, Genetics, Immunology, and Hematology.

Their work covers a range of topics related to lymphoid neoplasms and hematologic malignancies. Key topics in their research include:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • T-cell and Retrovirus Studies
  • Cutaneous lymphoproliferative disorders research
  • CNS Lymphoma Diagnosis and Treatment

Julie M. Vose has contributed extensively to the following publication venues:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • ONCOLOGY
  • Blood Advances

Their recent scholarly papers include:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium, 2020, Journal of Clinical Oncology
  • Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results, 2021, Blood
  • Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma, 2021, British Journal of Haematology
  • NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021, 2021, Journal of the National Comprehensive Cancer Network

Frequent collaborators in their research include:

  • Matthew A. Lunning
  • Ranjana H. Advani
  • André Goy
  • Umar Farooq
  • Abhinav Deol

Their work demonstrates a sustained engagement with lymphoma and hematologic oncology, reflected in contributions to topics such as CAR-T cell therapy and lymphoma classification. The research collectively spans clinical and translational studies, including consensus classification reports, clinical trial results, prophylactic treatment evaluations, and clinical guidelines insights.

Best Publications

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

    Julie M. Vose;M. Neumann;Mildred E. Harris

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Wyndham H. Wilson;Ryan M. Young;Roland Schmitz;Yandan Yang

  • ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project

    Kerry J. Savage;Nancy Lee Harris;Julie Marie Vose;Fred Ullrich

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

    Kenneth R. Carson;Andrew M. Evens;Elizabeth A. Richey;Thomas M. Habermann

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

    Jonathan W. Friedberg;Jeff Sharman;John Sweetenham;Patrick B. Johnston

  • Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

    Wing Yan Au;Dennis D. Weisenburger;Tanin Intragumtornchai;Shigeo Nakamura

  • A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

    William W L Choi;Dennis D. Weisenburger;Timothy Charles Greiner;Miguel A. Piris

  • Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma

    Randy D. Gascoyne;Patricia Aoun;Patricia Aoun;Patricia Aoun;Daniel Wu;Daniel Wu;Daniel Wu;Mukesh Chhanabhai;Mukesh Chhanabhai;Mukesh Chhanabhai

  • Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas

    M. S. Kaminski;A. D. Zelenetz;O. W. Press;M. Saleh

  • Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Douglas W. Blayney

  • Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma

    J. M. Vose;B. K. Link;M. L. Grossbard;M. Czuczman

  • Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

    Loretta J. Nastoupil;Michael D. Jain;Lei Feng;Jay Y. Spiegel

Frequent Co-Authors

James O. Armitage
James O. Armitage University of Nebraska Medical Center
Dennis D. Weisenburger
Dennis D. Weisenburger University of Nebraska Medical Center
Ranjana H. Advani
Ranjana H. Advani Stanford University
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Wing C. Chan
Wing C. Chan City of Hope
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Andrew D. Zelenetz
Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Nancy L. Bartlett
Nancy L. Bartlett Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in a flexible path towards a healthcare career in the USA, online medical degrees offer a variety of options to suit different needs and schedules. Busy professionals and aspiring medical workers can now upskill or change their career trajectory without sacrificing their current commitments.

Pursuing rn bsn online programs no clinicals allows registered nurses to earn their Bachelor of Science in Nursing fully online, without the traditional in-person clinical requirements. This option enables faster completion for those with existing experience.

Medical professionals seeking advanced practice roles should consider short dnp programs or even a 1 year dnp program online. These streamlined doctorate programs help nurses achieve leadership or specialist positions in less time.

For those aiming to quickly enter the healthcare workforce, there are also fast track medical programs. These options are ideal for students who want to become Licensed Practical Nurses and start serving patients sooner.

With more accredited, high-quality online programs available than ever, students can find pathways that fit their personal and professional goals while meeting licensure requirements.

Best Scientists Citing Julie M. Vose

Trending Scientists

Recently Published Articles